Zhongguo Dang Dai Er Ke Za Zhi. 2023 Jul 15;25(7):678-684. doi: 10.7499/j.issn.1008-8830.2302049.
To investigate the clinical characteristics of neonates infected with the Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
A cross-sectional survey was conducted on 542 hospitalized neonates with confirmed coronavirus disease 2019 (COVID-19) in 27 hospitals in Shenzhen from December 7, 2022, to January 12, 2023 (during the Omicron variant epidemic period). The neonates were divided into two groups: asymptomatic infection and symptomatic infection. The clinical characteristics, results of laboratory examination, chest X-ray findings, and outcome were compared between the two groups.
Among the 542 neonates, there were 285 males and 257 females. Among them, 515 (95.0%) were full-term infants, and 27 (5.0%) were preterm infants. The asymptomatic infection group had 60 cases, and the symptomatic infection group had 482 cases. Among them, 336 cases (69.7%) were mild, 125 cases (25.9%) were moderate, 15 cases (3.1%) were severe, and 6 cases (1.2%) were critical. Fever was the most common symptom (434 cases, 90.0%), followed by cough and/or spitting (183 cases, 38.0%), nasal congestion and/or runny nose (131 cases, 27.2%), shortness of breath (36 cases, 7.5%), and feeding intolerance (30 cases, 6.2%). Among the 325 cases who underwent chest X-ray examination, 136 cases (41.8%) had patchy or consolidative shadows in the lungs, 2 cases (0.6%) had pneumothorax, 2 cases (0.6%) had decreased lung transparency, and 185 cases (57.0%) showed no abnormality. Among the 396 cases (73.1%) who received treatment, 341 cases (86.1%) received symptomatic treatment, 137 cases (34.6%) received antibiotic treatment, 4 cases (1.0%) received immunoglobulin treatment, and 23 cases (5.8%) received respiratory support treatment. All 542 neonates were discharged from the hospital after their clinical symptoms were relieved, and the median hospital stay was 5 days. The white blood cell count, neutrophil count, hemoglobin, and procalcitonin were lower in the symptomatic infection group than those in the asymptomatic infection group (<0.05), while the platelet count and blood glucose levels were higher in the symptomatic infection group than those in the asymptomatic infection group (<0.05). The proportions of neonates with decreased neutrophil count, increased platelet count, and decreased hemoglobin concentration were higher in the symptomatic infection group than those in the asymptomatic group (<0.05).
Most neonates with COVID-19 caused by the Omicron variant of SARS-CoV-2 are mild, with fever as the predominant symptom. Symptomatic neonates with COVID-19 are often accompanied by decreased neutrophil count, increased platelet count, and decreased hemoglobin level. Symptomatic treatment is the main treatment, and the prognosis is good.
探讨感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎变异株的新生儿的临床特征。
于2022年12月7日至2023年1月12日(奥密克戎变异株流行期间),对深圳27家医院收治的542例确诊新型冠状病毒肺炎(COVID-19)的住院新生儿进行横断面调查。将新生儿分为两组:无症状感染组和有症状感染组。比较两组的临床特征、实验室检查结果、胸部X线表现及转归。
542例新生儿中,男285例,女257例。其中,足月儿515例(95.0%),早产儿27例(5.0%)。无症状感染组60例,有症状感染组482例。其中,轻症336例(69.7%),中症125例(25.9%),重症15例(3.1%),危重症6例(1.2%)。发热是最常见症状(434例,90.0%),其次为咳嗽和/或咳痰(183例,38.0%)、鼻塞和/或流涕(131例,27.2%)、呼吸急促(36例,7.5%)、喂养不耐受(30例,6.2%)。325例行胸部X线检查的患儿中,136例(41.8%)肺部有斑片状或实变影,2例(0.6%)有气胸,2例(0.6%)肺透明度降低,185例(57.0%)无异常。396例(73.1%)接受治疗的患儿中,341例(86.1%)接受对症治疗,137例(34.6%)接受抗生素治疗,4例(1.0%)接受免疫球蛋白治疗,23例(5.8%)接受呼吸支持治疗。542例新生儿临床症状缓解后均出院,中位住院时间为5天。有症状感染组白细胞计数、中性粒细胞计数、血红蛋白和降钙素原低于无症状感染组(<0.05),而有症状感染组血小板计数和血糖水平高于无症状感染组(<0.05)。有症状感染组中性粒细胞计数降低、血小板计数升高和血红蛋白浓度降低的新生儿比例高于无症状组(<0.05)。
大多数感染SARS-CoV-2奥密克戎变异株的COVID-19新生儿症状较轻,以发热为主要症状。有症状的COVID-19新生儿常伴有中性粒细胞计数降低、血小板计数升高和血红蛋白水平降低。对症治疗是主要治疗方式,预后良好。